Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy

PURPOSE: To compare the outcomes of treatment with intravitreal bevacizumab (IVB) versus observation in central serous chorioretinopathy (CSCR). METHODS: In a retrospective comparative study, records of 45 patients with CSCR were reviewed. Twenty-two patients received IVB (1.25 mg/0.05 ml) while 23...

Descripción completa

Detalles Bibliográficos
Autores principales: Ünlü, Cihan, Erdogan, Gurkan, Aydogan, Tugba, Sezgin Akcay, Betul Ilkay, Kardes, Esra, Kiray, Gulunay Akcali, Bozkurt, Tahir Kansu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860989/
https://www.ncbi.nlm.nih.gov/pubmed/27195087
http://dx.doi.org/10.4103/2008-322X.180700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860989/
https://www.ncbi.nlm.nih.gov/pubmed/27195087
http://dx.doi.org/10.4103/2008-322X.180700

Ejemplares similares